Health Affairs, 23, no. 3 (2004): 177-185 doi: 10.1377/hlthaff.23.3.177 © 2004 by Project HOPE	New Online   House Health Reform Bill   Paying for Reform   Vetting AHIP's Report   HIV/AIDS Costs   Brief: Insurance Reform   HA Blog Top 10

This Article Full Text (HTML) Reprint (PDF) Submit a response to this article Alert me when this article is cited Alert me when Comments are posted Alert me if a correction is posted Services E-mail this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to My Personal Archive Download to Citation Manager Reprints & Permissions Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (1) Citing Articles via Google Scholar Google Scholar Articles by Kleinke, J.D. Search for Related Content PubMed Articles by Kleinke, J.D. Related Collections Health Reform Legal/Regulatory Issues Pharmaceuticals Public Opinion Politics Consumer Issues

Interview

INTERVIEW

Think Globally, Protect Locally: A Conversation With Mark McClellan

Departing Food and Drug Administration (FDA) Commissioner Mark McClellan outlines the major initiatives of his sixteen-month tenure at the agency, including an expanded role for economic analysis in FDA policy, steps to promote "e-prescribing" and other information technologies, broadened use of external advisory panels to reduce political conflict between the agency and its various stakeholders, and an uncompromising stance against allowing U.S. citizens to reimport drugs from foreign sources. McClellan’s policy interests and positions at the FDA may offer some insight into his approach to future policy positions at the Centers for Medicare and Medicaid Services.

                      What's this?

This article has been cited by other articles:

				S. M. Teutsch, M. L. Berger, and M. C. Weinstein Comparative Effectiveness: Asking The Right Questions, Choosing The Right Method Health Aff., January 1, 2005; 24(1): 128 - 132. [Abstract] [Full Text] [PDF]